Medication Guide - 4/16/2021

Medication guides are FDA- approved documents that address issues that are specific to particular drugs, and can help patients avoid serious adverse events (side effects). This database does not include Medication Guides for FDA-approved allergenic or cellular/tissue products (see  FDA Online Label Repository  or DailyMed  for these Medication Guides).  More Drug Name Active Ingredient Form;Route Appl. No. Company Date Contrave Bupropion Hydrochloride; Naltrexone Hydrochloride TABLET, EXTENDED RELEASE;ORAL 200063 NALPROPION 04/14/2021 Tecentriq Atezolizumab INJECTABLE;INJECTION 761034 GENENTECH INC 04/13/2021 Trulance Plecanatide TABLET;ORAL 208745 SALIX 04/13/2021 Xiaflex Collagenase Clostridium Histolyticum SOLUTION; INJECTION 125338 AUXILIUM PHARMS 04/13/2021 Linzess Linaclotide CAPSULE;ORAL 202811 ALLERGAN 04/12/2021 Ozempic Semaglutide SOLUTION;SUBCUTANEOUS 209637 NOVO 04/12/2021 Xolair Omalizumab VIAL 103976 GENENTECH 04/09/2021 Qelbree Viloxazine Hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 211964 SUPERNUS PHARMS 04/02/2021 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA